Compare ARK Genomic Revolution ETF (ARKG) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Gigacloud Technology Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Gigacloud Technology Inc trades at $34.35 (market cap $1.25B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Gigacloud Technology Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GCT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $51.80 |
52-Week Low | $23.09 | $20.26 |
Market Cap | — | $1.25B |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GigaCloud Technology (GCT) trades at $34.41, down 1.21% today, with a bullish technical signal and strong fundamental performance. The company reported consistent earnings beats, with Q1 2026 EPS of $1.04 surpassing the $0.87 estimate, and maintains robust profitability with a 10.77% net income margin. Revenue growth is projected to rise from $1.29B in 2025 to $1.4B in 2026, supported by positive analyst sentiment and inclusion in TIME's World's Growth Leaders 2026 list.
The outlook for GCT is positive, driven by earnings momentum and strategic expansions into Europe and AI-edge technology. Key risks include market volatility, competitive pressures in the furniture sector, and potential fiduciary concerns highlighted in recent news. With 66.7% of analysts rating it a Buy and a $56 price target from Seeking Alpha suggesting 76% upside, the stock presents growth potential but requires monitoring of execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
